Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2026-01-22 @ 6:02 PM
Study NCT ID:
NCT01534403
Status:
COMPLETED
Last Update Posted:
2016-05-06
First Post:
2012-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects
Sponsor:
UCB Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-13
First Submit QC Date:
None
Study First Post Date:
2012-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-05-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-04-11
Last Update Post Date:
2016-05-06
Last Update Post Date Type:
ESTIMATED